You are viewing the site in preview mode
Skip to main content
Clinical feature of patients with CoV infection
SARS-CoV-2
MERS-CoV
SARS-CoV
Study (n )
Reports (n )
Pregnancies (n )
Pooled % (95%-CI)
Study (n )
Reports (n )
Pregnancies (n )
Pooled % (95%-CI)
Study (n )
Reports (n )
Pregnancies (n )
Pooled % (95%-CI)
Fever
19
575
870
66.1% [56.1–79.8]
6
9
12
75% [30.2–88.9]
7
32
33
96.9% [84.6–100]
Cough
18
458
869
52.7% [34.7–67.7]
4
7
9
77.8% [40.1–97.5]
6
21
26
80.8% [61.4–93.6]
Fatigue
8
192
634
30.3% [14.4–49.6]
1
1
2
50% [1.2–99.2]
–
–
–
–
Dyspnea
7
49
303
16.2% [7.6–22.3]
1
1
2
50% [1.4–99.6]
1
9
10
90% [55.3–100]
Myalgia
5
61
293
20.8% [7.5–27.8]
2
3
8
37.5 [9.3–76.2]
2
16
22
72.7% [50.1–89.8]
Shortness of Breath
6
186
586
31.7% [18.2–41.5]
1
1
2
50% [1.4–99.6]
3
9
24
37.5% [19.2–59.6]
Sore throat
6
78
668
11.7% [5.1–29.1]
–
–
–
–
2
5
22
22.7% [8.7–45.5]
Chill
3
44
480
9.2% [4.7–71.1]
–
–
–
–
3
15
23
65.2% [43.1–84.8]
Headache
5
88
674
13.1% [8.5–33.2]
1
1
2
50% [1.4–99.6]
4
15
24
62.5% [41.3–81.9]
Muscle pain
3
67
628
10.7% [4.9–25.4]
–
–
–
–
2
2
11
18.2% [3.2–35.9]
Diarrhea
9
41
753
5.4% [2.2–10.3]
1
1
2
50% [1.4–99.6]
2
3
22
13.6% [6.6–48.7]
Abdominal pain
2
5
64
7.8% [3.5–17.1]
1
1
2
50% [1.4–99.6]
–
–
–
–
Pneumonia
21
368
517
71.2% [68.6–95.8]
4
5
7
71.4% [29.5–96.2]
5
8
9
88.9% [52.1–100]
Laboratory finding
Leukocytosis
6
27
95
28.4% [20.1–39.6]
–
–
–
–
3
10
24
41.7% [22.1–63.2]
Leukopenia
6
43
95
45.3% [35.4–56.3]
–
–
–
–
3
14
24
58.3% [37.2–78.3]
Lymphocytosis
12
8
70
11.4% [5.5–21.3]
–
–
–
–
4
3
24
12.5% [3.2–32.8]
Lymphocytopenia
13
92
146
63% [55.7–71.4]
1
1
1
100% [3.3–100]
4
20
24
83.3% [63.1–95.5]
ALT↑
3
9
48
18.8% [9.5–33.7]
2
1
3
33.3% [1.6–91.3]
2
2
8
25% [3.3–65.3]
AST↑
3
8
48
16.7% [7.2–30.5]
2
1
3
33.3% [1.6–91.3]
2
2
8
25% [3.3–65.3]
LDH↑
3
8
23
34.8% [16.2–57.9]
–
–
–
–
–
–
–
–
C-reactive protein ↑
11
80
143
55.9% [47.4–64.2]
1
1
1
100% [3.3–100]
1
1
1
100% [3.3–100]
AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase
